Automata Technologies, a London, UK-based automation company for life sciences labs, raised $40M in funding.
The round was led by Dimension with participation from A.P. Moller Holding, parent company of the A.P. Moller Group and returning investors, Octopus Ventures, Hummingbird, Isomer Capital, Possible Ventures and Aldea Ventures.
The company intends to use the funds to accelerate its growth and industry presence across the US, UK and EMEA.
Led by CEO Mostafa Elsayed, Founder and CEO, Automata is a robotics and automation company for laboratories to automate technology processes. Its LINQ automation platform includes:
- Software that empowers scientists to design, schedule and run their workflows.
- Proprietary hardware that acts as the core of a lab’s robotics ecosystem enabling modular configurations, higher throughputs and parallel workflows.
- Data availability at every stage of an experiment or workflow.
- OEM agnostic approach to third party instrumentation allowing integration with a variety of labs and equipment
Customers include NHS Trusts such as The Royal Marsden NHS Foundation Trust, academic institutions including The Francis Crick Institute, testing labs such as HSL, CDMOs and CROs, pharma and biotech companies, such as Astra Zeneca and bit.bio.
FinSMEs
03/10/2023